Mark S. Kamlet
Mark S. Kamlet is University Professor of Economics and Public Policy and Provost Emeritus at Carnegie Mellon University, with joint appointments in the Department of Social and Decision Sciences in the Dietrich College of Humanities and Social Sciences and the Heinz College of Information Systems and Public Policy. Dr. Kamlet has served on the National Academies’ Committee in Poison Prevention and Control, 2003–2004; Board on Population Health and Public Health Practice, 2002–2006; and the Committee on Management of University Intellectual Property, 2008–2011. He is an elected fellow of the American Association for the Advancement of Science. Kamlet earned his bachelor’s degree in mathematics from Stanford University. He has a master’s in mathematical statistics, a masters in economics, and a Ph.D. in economics from the University of California at Berkeley.
Arti K. Rai
Arti Rai, Elvin R. Latty Professor of Law and faculty director of The Center for Innovation Policy at Duke University School of Law, is an internationally recognized expert in intellectual property law, innovation policy, administrative law, and health law. Professor Rai’s current work focuses on the intersection of trade secrecy incentives and explainability in artificial intelligence-enabled health care delivery. From 2009 to 2010, Professor Rai served as the administrator of the Office of External Affairs at the U.S. Patent and Trademark Office. Professor Rai has also served on the National Academies’ Committee on Understanding the Global Public Health Implications of Substandard, Falsified, and Counterfeit Medical Products (2012–2013) and on the Committee on Strategies for Responsible Sharing of Clinical Trial Data (2013–2015), in addition to reviewing reports for other committees. Professor Rai graduated from Harvard College, magna cum laude, with a degree in biochemistry and history (history and science), attended Harvard Medical School for the 1987–1988 academic year, and received her J.D., cum laude, from Harvard Law School in 1991.
Joel Waldfogel is associate dean of MBA Programs and the Frederick R. Kappel Chair in Applied Economics, Strategic Management, and Entrepreneurship at the Carlson School of Management of the University of Minnesota. His main research interests are industrial organization and law and economics, and he has conducted empirical studies of price advertising, media markets, the operation of differentiated product markets, and issues related to digital products, including piracy, pricing, and revenue sharing. Dr. Waldfogel previously served as a member on the National Academies’ Committee to Improve Research Information and Data on Firearms (2001–2005) and of the Committee on the Impact of Copyright Policy on Innovation in the Digital Era (2010–2013). Dr. Waldfogel received a B.A. in economics from Brandeis University and a Ph.D. in economics from Stanford University.
John T. Wilbanks is the chief commons officer at Sage Bionetworks, where he works to promote the use of technology to pool medical data, creating a commons where information is integrated and accessible. Mr. Wilbanks is also a Senior Fellow at Faster Cures and Founder at Consent to Research. He co-founded the Access to Research campaign, which resulted in increased accessibility to results of federally funded scientific research, and he started a bioinformatics company called Incellico, which became a part of Selventa in 2003. Mr. Wilbanks serves on the board of directors for Impact Story and the tranSMART Foundation, as well as on the advisory boards for Boundless Learning, Curious, GenoSpace, and Patients Like Me.
Mr. Wilbanks served as a senior fellow at the Ewing Marion Kauffman Foundation, was a senior advisor for big data to the National Coordination Office, and has past affiliations with Massachusetts Institute of Technology's Project on Mathematics and Computation, which hosts Creative Commons, a nonprofit organization that enables knowledge sharing through free legal tools. He has also worked with Harvard University's Berkman Center for Internet & Society, the World Wide Web Consortium, the U.S. House of Representatives, and Creative Commons. He has numerous publications on data sharing, and a chapter titled "I Have Seen the Paradigm Shift, And It Is Us," in The Fourth Paradigm: Data-Intensive Scientific Discovery (Microsoft Research, 2009).
Mr. Wilbanks has prior National Academies experience, serving on the Planning Committee for the Workshop on 21st Century Clinical Trials (May – December 2018) and on the Committee on Developing Attribution and Citation Practices and Standards (2011 – 2012). He also has spoken at NAM meetings and events. Mr. Wilbanks received a B.A. in philosophy from Tulane University and studied modern letters at the Sorbonne.
Jetta Wong is President of JLW Advising, her consulting practice, where she advises clients on how to bring new clean energy technologies to the market. One of her main clients is the Los Angeles Cleantech Incubator, a private, non-profit organization that works with startups to accelerate the commercialization of clean technologies. Before joining LACI, Ms. Wong established the Office of Technology Transitions for the United States Department of Energy (DOE) and served as its first director. She joined DOE in 2012 in the Office of Energy Efficiency and Renewable Energy, where she worked on clean energy manufacturing and led the office’s National Laboratory Impact Initiative. Before joining DOE, Ms. Wong worked for the U.S. House of Representatives’ Committee on Science, Space, and Technology, where she helped establish and oversee energy and environment programs of the federal government. Ms. Wong holds a MPS in legislative affairs from George Washington University and a B.S. in natural resources and the environment from the University of Michigan.
Gail Cohen - (Staff Officer)